Macrophage migration inhibitory factor (MIF) is a pluripotent cytokine that has an essential role in the pathophysiology of experimental allergic inflammation. Recent findings suggest that MIF is involved in several allergic disorders, including atopic dermatitis (AD). In this study, the role of MIF in allergic skin inflammation was examined using a murine model of AD elicited by epicutaneous sensitization with ovalbumin (OVA). We observed the number of skin-infiltrating eosinophils to significantly increase in OVA-sensitized MIF transgenic (Tg) mice compared with their wild-type (WT) littermates. On the other hand, eosinophils were virtually absent from the skin of MIF knockout (KO) mice and failed to infiltrate their skin after repeated epicutaneous sensitization with OVA. The mRNA expression levels of eotaxin and IL-5 were significantly increased in OVAsensitized skin sites of MIF Tg mice, but were significantly decreased in MIF KO mice in comparison with the levels in WT littermates. Eotaxin expression was induced by IL-4 stimulation in fibroblasts in MIF Tg mice, but not in MIF KO mice. These findings indicate that MIF can induce eosinophil accumulation in the skin. Therefore, the targeted inhibition of MIF might be a promising new therapeutic strategy for allergic skin diseases.
INTRODUCTION
Atopic dermatitis (AD) is a chronic, relapsing inflammatory disease of the skin with significant morbidity and an adverse impact on patient well-being (Morar et al., 2006) . AD is considered to result from a dysregulation of the normal interactions between the environment and genes, defects in skin barrier function, and systemic and local immunological responses (Leung et al., 2004) . The contribution of the immune response to the pathogenesis of AD has been attributed largely to abnormalities in adaptive immunity, with key roles being played by T-helper 1(Th1)/Th2 cell dysregulation, IgE production, dendritic cell signaling, and mast-cell hyperactivity, leading to the pruritic, inflammatory dermatosis that characterizes AD (Leung et al., 2004) . In addition, accumulation of eosinophils is characteristic of the inflammation associated with AD (Honma et al., 2000) .
Macrophage migration inhibitory factor (MIF) was the first lymphokine reported to prevent random migration of macrophages (Bloom and Bennett, 1966) . As the molecular cloning of MIF complementary DNA (Weiser et al., 1989) , MIF has been re-evaluated as a proinflammatory cytokine and pituitary-derived hormone that potentiates endotoxemia (Bernhagen et al., 1993; Bucala, 1996) . MIF has an important role in delayed-type hypersensitivity (Bernhagen et al., 1998) . Recently, it has been demonstrated that MIF also upregulates the expression of Toll-like receptor-4, which mediates lipopolysaccharide binding and activation of macrophages (Roger et al., 2001) . MIF is now recognized as a cytokine that exhibits a broad range of immune and inflammatory activities, including induction of inflammatory cytokines, and regulation of macrophage and lymphocyte proliferation. Furthermore, MIF induces the endothelial expression of E-selectin, ICAM-1, vascular cell adhesion molecule-1, IL-8, and monocyte chemoattractant protein-1, thus resulting in leukocyte recruitment (Gregory et al., 2004 (Gregory et al., , 2006 Cheng et al., 2010) . MIF originates from multiple cellular sources such as activated T lymphocytes, monocytes, eosinophils, and keratinocytes (Rossi et al., 1998; Shimizu et al., 1999; Yamaguchi et al., 2000) . MIF has also been shown to exacerbate human allergic and inflammatory diseases, such as asthma (Rossi et al., 1998) and acute respiratory distress syndrome (Donnelly et al., 1997) .
We recently reported excessive expression of MIF mRNA and protein in inflammatory skin lesions and in sera from AD patients (Shimizu et al., 1999; Shimizu, 2005) . We also showed that the serum MIF levels decrease as the clinical features of this disease improve, thus suggesting that MIF has a pivotal role in the inflammatory response in AD (Shimizu et al., 1997) . These studies raise the possibility that MIF is an important component of Th2-mediated immunopathology in general, and might therefore be relevant to chronic inflammatory allergic conditions. Eosinophils may aggravate the inflammatory response in the skin of AD patients. Spergel et al. (1998 Spergel et al. ( , 1999 ) reported a murine model of allergic skin inflammation elicited by epicutaneous sensitization with ovalbumin (OVA). This model displays many of the features of human AD, including elevated total and specific IgE, dermatitis characterized by infiltration of the dermis by CD4
þ T cells and eosinophils, and increased local expression of mRNAs for the cytokines IL-4, IL-5, and IFN-g. In our present study, MIF transgenic (Tg) mice and MIF knockout (KO) mice were used to assess the potential role of MIF in the pathogenesis of AD in this murine model of allergic skin inflammation. We also investigated the effects of MIF on eotaxin expression of dermal fibroblasts.
RESULTS
The expression of MIF was increased in bone marrow and skin from MIF Tg mice MIF Tg mice exhibited no lethal or prominent pathological lesions in the organs examined. A northern blot analysis revealed the MIF mRNA expression in bone marrow and skin from MIF Tg mice to be B10 times higher than that in wildtype (WT) mice (Figure 1a ). MIF protein was also increased in the skin from MIF Tg mice compared with that from WT mice, as demonstrated by western blotting (Figure 1b ).
OVA-sensitized skin sites of MIF Tg mice showed marked eosinophil infiltration
To examine the role of MIF in eosinophilic infiltration, MIF Tg and WT mice were subjected to epicutaneous OVA sensitization. Only a few eosinophils were present in saline-sensitized skin from MIF Tg and WT mice, while eosinophilic infiltration of the dermis was significantly increased following epicutaneous sensitization with OVA. The mean number of eosinophils after OVA sensitization was 13.6±2.84 in MIF Tg mice, but only 4.8±1.37 in WT mice (Po0.001; Figure 2a ). Figure  2b shows the histological features of OVA-sensitized skin sites in MIF Tg and WT mice. The epidermis was slightly thickened, and numerous eosinophils and mononuclear cells infiltrated the upper dermis around the vessels, in the OVA-sensitized skin of MIF Tg mice.
Eosinophil numbers were not increased in the OVA-sensitized skin of MIF KO mice
To further clarify the roles of MIF in eosinophilic infiltration, MIF KO mice were subjected to epicutaneous OVA sensitization. The mean number of eosinophils after OVA sensitization was 2.0 ± 0.94 in MIF KO mice, and did not differ from that after saline sensitization. Furthermore, this value was significantly lower than that of WT mice (4.8 ± 1.37, Po0.05; Figure 3a ). Histological features also confirmed only a few eosinophils to be present in the dermis after OVA sensitization in MIF KO mice (Figure 3b ).
The expression of eotaxin and Th2-type cytokines increased in the OVA-sensitized skin of MIF Tg mice, but decreased in the OVA-sensitized skin in MIF KO mice
We next examined the expression of mRNAs for eotaxin and cytokines in OVA-sensitized skin specimens from MIF Tg, MIF KO, and WT mice. The expression levels of eotaxin and Th2-type cytokines, especially IL-5, were increased in the OVA-sensitized skin of MIF Tg mice compared with WT mice. However, IFN-g, a Th1-type cytokine, did not differ between MIF Tg and WT mice. Conversely, low eotaxin mRNA expression was observed in the OVA-sensitized skin of MIF KO mice compared with WT mice. Similarly, the mRNA expression of the Th2-type cytokines, including IL-4, IL-5, and IL-13, were low in the OVA-sensitized skin of MIF KO mice compared with WT mice (Figure 4 ).
The expression and production of eotaxin in cultured fibroblasts from MIF Tg mice and from MIF KO mice
To clarify the role of MIF in the expression of eotaxin, we performed in vitro experiments. A previous report described that IL-4 could dose-dependently induce the expression of eotaxin mRNA in dermal fibroblasts from humans and mice (Mochizuki et al., 1998) . Using this protocol, we analyzed the eotaxin expression in cultured fibroblasts from MIF Tg, MIF KO, and WT mice by stimulating them with IL-4. Unstimulated fibroblasts from these mice barely expressed eotaxin mRNA. However, fibroblasts from MIF Tg mice showed dramatically increased eotaxin mRNA after stimulation with 5 ng ml À1 of IL-4 ( Figure 5a ). To evaluate whether there was an accompanying change in eotaxin protein production, the amount of eotaxin in fibroblast supernatants was also analyzed. Eotaxin proteins in the culture supernatant of fibroblasts from MIF Tg mice were also significantly increased compared with those from WT mice (*Po0.005). However, fibroblasts from MIF KO mice showed minimal expression of eotaxin mRNA even when stimulated with 10 ng ml À1 of IL-4. Eotaxin production in the culture supernatant of fibroblasts from MIF KO mice was barely detectable (Figure 5b ).
Recombinant MIF restored the expression and production of eotaxin in dermal fibroblasts from MIF KO mice
In dermal fibroblasts from WT mice, stimulation with IL-4 significantly induced the expression of eotaxin mRNA compared with unstimulated fibroblasts (Figure 6a ). Addition of recombinant MIF significantly enhanced this increase in eotaxin expression. This suggests that the eotaxin expression in dermal fibroblasts from MIF Tg mice was markedly increased by IL-4 stimulation. A significant amount of eotaxin was also produced by combined stimulation with IL-4 (*Po0.005, **Po0.05; Figure 6b ). Although the fibroblasts from MIF KO mice showed minimal induction of eotaxin mRNA expression in response to stimulation with IL-4, both the expression of eotaxin mRNA and the production of eotaxin protein were restored by addition of recombinant MIF ( Figure 6a and b) . The levels of eotaxin production in MIF KO mouse fibroblasts exposed to MIF were similar to the levels in WT fibroblasts stimulated with IL-4 (Figure 6b ).
DISCUSSION
There is growing evidence that the eosinophil is an important effecter cell in allergic inflammatory diseases, such as asthma and AD. Accumulation of eosinophils in the skin is characteristic of inflammation associated with AD (Leiferman, 1989; Kapp, 1995) . This study explored, for the first time, the significant increase in eosinophil infiltration in the skin of MIF Tg mice after OVA sensitization, compared with WT mice. However, in MIF KO mice, eosinophils failed to infiltrate the skin after repeated epicutaneous sensitization with OVA. Eosinophils accumulate at inflammatory sites and release numerous mediators capable of initiating and maintaining allergic inflammation. Yamaguchi et al. (2000) reported eosinophils to be an important source of MIF in allergic inflammatory diseases. The number of eosinophils was reported to be significantly decreased in lung tissue and in bronchoalveolar lavage fluid from MIF KO mice after stimulation with OVA, compared with those from WT mice (Mizue et al., 2005; Magalhães et al., 2007; Wang et al., 2009) . In an allergic rhinitis model, eosinophil recruitment into the nasal submucosa was also suppressed in MIF KO mice (Nakamaru et al., 2005) . Consistent with these findings, our current evidence indicates that MIF is essential for the infiltration of eosinophils into the OVAsensitized skin.
This study also demonstrated that the expression of both eotaxin and IL-5 is markedly increased in the OVA-sensitized The eotaxin contents of cultured supernatants were analyzed for eotaxin by ELISA. Each value represents the mean ± SD of six specimens. *Po0.005, **Po0.05. GAPDH, glyceraldehyde-3-phosphate dehydrogenase; ND, not detected. skin sites of MIF Tg mice skin. The other Th2-type cytokines, IL-4 and IL-13, were also slightly increased in MIF Tg mice. On the other hand, the expression levels of eotaxin and Th2-type cytokines were markedly decreased in the OVAsensitized skin sites of MIF KO mice. Acute AD involves a systemic Th2 response with eosinophilia, and marked infiltration of Th2 cells into skin lesions. These infiltrating T cells predominantly express IL-4, IL-5, and IL-13. Furthermore, the roles of cytokines in the induction of migration and the accumulation of eosinophils into an inflamed tissue have been extensively studied in recent years. Some of the important eosinophil chemoattractant cytokines include IL-5, IL-8, eotaxin, RANTES (regulated on activation, normal T cell expressed and secreted), and monocyte chemoattractant protein-3 (Lampinen et al., 2004) . Among these, eotaxin (CC chemokine ligand-11) is one of the most important eosinophil-selective chemoattractants (Jose et al., 1994; Garcia-Zepeda et al., 1996) . Eotaxin is secreted by several cell types: epithelial cells, fibroblasts, and activated infiltrating leukocytes such as eosinophils (Garcia-Zepeda et al., 1996; Ponath et al., 1996; Uguccioni et al., 1996) . Eotaxin is reportedly related to the eosinophilia in allergic diseases, including AD and asthma (Ying et al., 1997; Yawalkar et al., 1999) . IL-5 also has an important role in eosinophil development and differentiation (Sanderson, 1992) . IL-5 KO mice had virtually no eosinophils in either saline-sensitized skin or in OVA-sensitized skin (Spergel et al., 1999) . Recently, Magalhães et al. (2009) reported that MIF was involved in IL-5-driven maturation of eosinophils and in tissue eosinophilia associated with Schistosoma mansoni infection. In addition, several earlier studies demonstrated that MIF KO mice failed to develop tissue eosinophilia, and that eotaxin, IL-4, and IL-5 were not induced in either allergic lung tissues or bronchoalveolar lavage fluid (Mizue et al., 2005; Wang et al., 2006) . Accordingly, our results suggest that MIF is important in regulating both eotaxin and IL-5 in OVA-sensitized inflamed skin tissue.
In support of these in vivo observations, this study demonstrated that the expression of eotaxin was significantly increased after stimulation with IL-4 in fibroblasts from MIF Tg mice compared with WT fibroblasts, but not in fibroblasts from MIF KO mice. However, eotaxin expression in fibroblasts from MIF KO mice was restored by addition of recombinant MIF. These observations suggest that MIF is crucial to the expression of eotaxin, and antigen-induced eosinophil infiltration is suspected to be induced by eotaxin mainly by MIF, in addition with IL-5 production involved in MIF. Previous observations have shown that either IL-4 or IL-13 can increase eotaxin expression, and that they function synergistically with proinflammatory cytokines, such as tumor necrosis factor-a, to increase the production of eotaxin in epithelial cells and fibroblasts (Mochizuki et al., 1998; Nakamura et al., 1998; Li et al., 1999; Stellato et al., 1999; Fujisawa et al., 2000; Terada et al., 2000) . Increases in both IL-4 and IL-13 in the inflamed skin of MIF Tg mice might involve enhancing the tissue eosinophilia. Furthermore, tumor necrosis factor-a secretion induced by MIF also has the ability to increase eotaxin expression in MIF Tg mice, on the basis of the known capacity of MIF to trigger the secretion of several inflammatory cytokines, including tumor necrosis factor-a (Donnelly et al., 1997) . It was recently elucidated that MIF activates an extracellular signal-regulated kinase-1/2-mitogen-activated protein kinase signaling through its receptor CD74 (Leng et al., 2003) and c-Jun Nterminus kinase-mitogen-activated protein kinase signaling through CD74/CXCR4 (Lue et al., 2011) , in addition to the endocytic pathway described previously (Kleemann et al., 2000) ; however, the receptor-mediated mechanism involved in MIF-mediated IL-4-induced eotaxin release is unclear. This mechanism should therefore be an important focus of research in association with MIF-mediated skin allergy.
Finally, we suggest that the inhibition of MIF might be an effective treatment for AD, suppressing both eosinophil infiltration and eotaxin expression in the skin. We recently demonstrated that in murine models of AD, MIF-DNA vaccination elicited the production of endogenous anti-MIF antibodies, producing rapid improvement of AD skin manifestations (Hamasaka et al., 2009) . Our previous data and the current findings therefore hold promise for the development of MIF inhibitors as a therapeutic strategy for allergic diseases.
MATERIALS AND METHODS

Materials
The following materials were obtained from commercial sources: a mouse eotaxin-specific ELISA kit from Genzyme TECHNE (Cambridge, MT); Isogen RNA extraction kit from Nippon Gene (Tokyo, Japan); M-MLV reverse transcriptase from GIBCO (Grand Island, NY); Taq DNA polymerase from Perkin-Elmer (Norwalk, CO); nylon membranes from Schleicher & Schuell (Keene, NH); FicollPlaque Plus and Protein A Sepharose from Pharmacia (Uppsala, Sweden); recombinant mouse IL-4 from R&D systems (Minneapolis, MN). Recombinant rat MIF (this recombinant MIF crossreacts with that of mice) was expressed in Escherichia coli BL21/DE3 (Novagen, Madison, WI) and was purified as described previously (Shimizu et al., 2004) . All other chemicals were of analytical grade.
Mice
The MIF-overexpressing Tg mice were established after complementary DNA microinjection. Physical and biochemical characteristics, including body weight, blood pressure, and serum cholesterol and blood sugar levels, were normal, as reported previously (Sasaki et al., 2004) . The transgene expression was regulated by a hybrid promoter composed of the cytomegalovirus enhancer and the b-actin/b-globin promoter, as reported previously (Akagi et al., 1997) . The strain of the original MIF Tg mice was ICR, which were backcrossed with C57BL/6 for at least 10 generations. Tg mice were maintained by heterozygous sibling mating. Aged MIF Tg mice of 12 months or older developed neither skin allergies nor diseases. The MIFdeficient (KO) mice were established by targeted disruption of the MIF gene as described previously (Honma et al., 2000) , using a mouse strain bred onto a C57BL/6 background. MIF Tg, MIF KO, and WT mice were maintained under specific-pathogen-free conditions at the Institute for Animal Experiments of the Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama. All experiments were performed on 8-week-old female adult mice.
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Epicutaneous sensitization Epicutaneous sensitization of mice was performed as described previously (Spergel et al., 1998) . Briefly, each mouse was anesthetized with 10% nembutal (Hospira, Osaka, Japan), then shaved with a razor. One hundred mg of OVA (Sigma, St Louis, MO) in 100 ml of normal saline were placed on a 1 Â 1 cm patch (Alcare, Tokyo, Japan), which was secured to the skin with a transparent bio-occlusive dressing (ALCARE). The patch was left in place for 1 week and then removed. At the end of the second week, an identical patch was reapplied to the same skin site. Each mouse had a total of three 1-week exposures to the patch, separated from each other by 2-week intervals. Inspection confirmed that the patch was still in place at the end of each sensitization period. Skin biopsies from treated areas were obtained for RNA isolation and histological evaluation. Six-micrometer thick skin sections were stained with hematoxylin and eosin (H&E). Eosinophils were counted under a microscope at a magnification of Â 400 and expressed as the mean number of the cells in five random fields (one section per mouse, five mice per group).
Northern blot analysis
Bone marrow cells were isolated from the femurs of MIF Tg or WT mice, and 1 Â 10 6 cells ml À1 was collected. Total RNA was isolated from bone marrow cells and skin from mice using an Isogen RNA extraction kit according to the manufacturer's protocols. The radioactive bands were visualized by autoradiography on Kodak X-AR5 film (Tokyo, Japan) and quantitatively analyzed using the NIH Image system (Bethesda, MD). The results were normalized by compensating for the glyceraldehyde-3-phosphate dehydrogenase mRNA levels.
Reverse transcription-PCR analysis
Total RNA was extracted from each mouse skin specimen. RNA reverse transcription was performed with M-MLV reverse transcriptase using random hexamer primers and subsequent amplification using Taq DNA polymerase. PCR was carried out for 35-40 cycles with denaturation at 94 1C for 30 seconds, annealing from 46 to 64 1C for 1 minute and extension at 72 1C for 45 seconds using a thermal cycler (PE Applied Biosystems Gene Amp PCR system 9700, Life Technologies Japan, Tokyo, Japan). The primers used in this study are described in Supplementary Table S1 online. After PCR, the amplified products were analyzed by 2% agarose gel electrophoresis.
Western blot analysis
The epidermis of each mouse was homogenized with a Polytron homogenizer (Kinematica, Lausanne, Switzerland). The protein concentrations of the cell homogenates were quantified using a Micro BCA protein assay reagent kit (Thermo Fisher Scientific, Yokohama, Japan). Equal amounts of homogenates were dissolved in 20 ml of Tris-HCL, 50 mM (pH 6.8), containing 2-mercaptoethanol (1%), SDS (2%), glycerol (20%) and bromophenol blue (0.04%), and then were heated to 100 1C for 5 minutes. The samples were then subjected to SDS-PAGE and electrophoretically transferred onto a nitrocellulose membrane. The membranes were blocked with 2.5% non-fat dry milk powder in phosphate-buffered saline, probed with antibodies against MIF (Shimizu et al., 1996) and subsequently reacted with secondary IgG antibodies coupled with horseradish peroxidase. The resultant complexes were processed for the ECL detection system (Amersham Biosciences, Buckinghamshire, UK). The relative amounts of proteins associated with specific antibodies were normalized according to the intensities of b-actin (Sigma).
Cell culture
Skin specimens were obtained from the dorsal surfaces of newborn MIF Tg, MIF KO, and WT mice. The skin specimens were cut into 3-5 mm pieces and placed on a large Petri dish with the subcutaneous side down, followed by tissue incubation for 1 week in a humidified atmosphere of 5% CO 2 at 37 1C. Once sufficient numbers of fibroblasts had migrated out of the skin sections, pieces of the skin were removed and the cells were passaged by trypsin digestion in the same manner as wound-harvested fibroblasts. Fibroblasts were grown in DMEM containing 10% fetal calf serum and 1% penicillin/streptomycin. After 3 passages, the fibroblasts were used for the experiments. The fibroblasts from MIF KO and WT mice were stimulated with MIF (100 ng ml
À1
), IL-4 (10 ng ml À1 ), or MIF (100 ng ml À1 ) in combination with IL-4 (10 ng ml À1 ) for 24 hours. We also stimulated the fibroblasts from MIF Tg, MIF KO, and WT mice with IL-4 (5 or 10 ng ml
) alone for 24 hours. The cells were analyzed using reverse transcriptase-PCR. Culture supernatants were analyzed for eotaxin by ELISA.
Statistical analysis
Values are expressed as the means±SD of the respective test or control group. The statistical significance of differences between the control and test groups was evaluated by either Student's t-test or one-way analysis of variance.
